NCT03148236View on ClinicalTrials.gov

Vitamin C in Atrial Fibrillation Ablation

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 18, 2017

Primary Completion Date

March 13, 2018

Study Completion Date

March 13, 2018

Conditions
Atrial Fibrillation Ablation
Interventions
DRUG

Vitamin C

200mg/kg/day split into 4 doses infused every six hours over 30 minutes in 50ml D5W

OTHER

Placebo

50mL infused over 30 minutes

Trial Locations (1)

23298

Virginia Commonwealth University, Richmond

All Listed Sponsors
lead

Virginia Commonwealth University

OTHER

NCT03148236 - Vitamin C in Atrial Fibrillation Ablation | Biotech Hunter | Biotech Hunter